Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic Cancer
Clinical trial NCT05795920 · UNKNOWN
Trial details
- NCT number
- NCT05795920
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-07-08
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.